CPhA offers our drug and therapeutic content in 2 subscription options to suit your needs.
Already a subscriber?
Purchase a CPS Subscription
Hospital, Clinic or Institution?
We offer options for Hospitals, Clinics and Academics with 11 or more clinicians. If you are buying 10 or more licences, contact us for bulk pricing options.
CPS Drug Information
The Canadian standard for drug monographs contains thousands of products, including monographs for drugs, vaccines, natural health products and medical devices, approved by Health Canada. Includes critical updates such as warnings, advisories, and drug shortages; and useful tools such as medical calculators, Clin-Info, Pill Identifier and Lexi-Interact drug interaction checker.
CPS Full Access
Includes the most current, evidence-based therapeutic information and non-prescription therapy for most common conditions, with cross-referenced drug tables and algorithms. Includes CPS Drug Information, critical updates such as warnings, advisories, and drug shortages; and useful tools such as medical calculators, Clin-Info, Pill Identifier and Lexi-Interact drug interaction checker.
*All subscriptions include access to the CPS mobile app.
How to access the CPS App
- Purchase a subscription.
- Download the iOS or Android app.
Looking for more information on CPS features and tools?
View our user guide for a complete overview of what's included in CPS Full Access.
|PRODUCT TYPE||CPS Web||CPS Mobile App|
|SUBSCRIPTION TYPE||CPS Drug Information||CPS Full Access||CPS Drug Information||CPS Full Access|
|CPS monographs & CPhA monographs|
|Products for Minor Aliments|
|Drug Tables/Drug Choices|
|Information for the patient: Minor Ailments|
|Patient Medication Information: Drug Monographs|
|Lexi drug interaction checker|
|Pill Identifier tool|
|Clin-Info drug-food interactions tool|
|Interactive medical calculators|
|Health Canada Advisories|
|drugshortages.ca linked from monographs|
|CPS Notifications linked from monographs|
|Product images linked from monographs|
|Full listing of Health Canada Warnings and Recalls|
|Public Drug Programs|
Each therapeutic topic is written by an expert author and is based on the best available evidence. CPhA employs a rigorous review process to ensure that the information is accurate and unbiased. Content is extensively reviewed and validated by skilled CPhA clinical editors and by external reviewers who are recognized experts (physicians and pharmacists) in their particular clinical area.
CPhA asks authors to disclose any potential conflicts of interest. CPhA does not accept funding from pharmaceutical manufacturers for any content that we develop.